Pure H2O Bio Technologies (CE) (USOTC:PRHB)
Historical Stock Chart
From Feb 2020 to Feb 2025
![Click Here for more Pure H2O Bio Technologies (CE) Charts. Click Here for more Pure H2O Bio Technologies (CE) Charts.](/p.php?pid=staticchart&s=NO%5EPRHB&p=8&t=15)
Pure H2O Bio-Technologies, Inc. (Pink
Sheets:PRHB) announced today its concerns over metropolitan water
systems. There have been recent public concerns in Colorado and Florida
regarding failures in their metropolitan water systems. Many are due to
the aging delivery systems that are breaking down at the point of entry
or point of use, which results in high levels of contamination with
pathogenic microorganisms. Although the most common contaminants will be
organisms such as E. coli, Salmonella, or Pseudomonas, there has been a
significant rise in organisms that are resistant to chlorine and related
halogens such as fluorine and bromine. The general way that metropolitan
water districts try to solve the problem is by flushing out the system
and the introduction of high levels of free chlorine (a very toxic
substance which is also corrosive to the pipes used to deliver water to
the public).
"This extremely important disinfection technology developed by PRHB will
provide an opportunity to address the concerns around the world on clean
water. Recent public concerns over unacceptable contaminants in public
water are increasing," said the Executive Producer of the Global News
Group. "I am looking forward to presenting the story in an upcoming
Special Edition report on this very important breakthrough."
In the recent past, there has been a significant increase in
Cryptosporidium detected in public swimming pools throughout the
country. Further, Noroviruses have entered the environment, namely on
cruise ships. This means that infected individuals will continue to
spread such pathogens and they will very likely enter the drinking water
systems at increasing rates. Organisms such as Cryptosporidium, Giardia,
and various viruses are virtually resistant to treatment with chlorine
and other related halogens as well as chemicals such as pesticides and
various prescription/over-the-counter pharmaceuticals. These organisms
are not resistant to treatment with the SilverTTO which has been tested
by Pure H2O Bio-technologies, Inc., (PRHB) in laboratory level studies
and is now being verified with the state-of-the-art patent-pending
treatment/delivery system that is underway. The system is also designed
to remove chemical contaminants and metals that are present in source
water. Certification of this system through EPA's contractor, National
Sanitation Foundation (NSF) is expected to be completed within a few
short months and has a high likelihood for success. This system will be
available to individuals and hospitals as a system delivering
"pathogen-free and chemical-free" water.
Pure H2O Bio-Technologies, Inc., www.pureh20biotech.com,
has been developing a water treatment system designed to kill the
pathogenic microbes such as those cited above and to deliver highly
purified water at the point-of-entry (POE) and point-of-use (POU),
namely for residential, commercial, hospital and medical facilities.
"Our potable water disinfection systems, in the near-final and
certification testing stages, can provide both disinfection and
purification of the contaminated water. On July 31, 2007, the Company
was awarded patent #7250111, and two additional patents pending at this
time that are under review with the U.S. Patent and Trademark Office,
Washington, D.C.," stated Joseph P. Doxey, President of Pure H2O
Bio-Technologies, Inc.
About Pure H2O Bio-Technologies, Inc.: Pure H2O Bio-Technologies, Inc.
(PRHB) is a publicly held company specializing in the manufacturing,
design, and sale of its unique residential, commercial and hospital
point-of-use potable water disinfection systems. These systems are
specifically designed to work effectively against water-borne pathogens
and remove heavy metals and objectionable biomasses.
The foregoing press release contains forward-looking statements that can
be identified by such terminology as "expects," "potential," "suggests,"
"may," "intends," or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties, and other
factors that may cause the actual results to be materially different
from any future results, performance or achievements expressed or
implied by such statements. In particular, management's expectations
regarding future research, development, and/or commercial results could
be affected by, among other things, uncertainties relating to the
availability of future financing; unexpected regulatory delays or
government regulation generally; the Company's ability to obtain or
maintain patent and other proprietary intellectual property protection;
and completion in general. Forward-looking statements speak only as to
the date they were made. The Company does not undertake to update
forward-looking statements to reflect circumstances or events that occur
after the date the forward-looking statements are made.